Gastroenterology
Volume 123, Issue 4 , Pages 1135-1143, October 2002

Neurotensin receptor–1 and –3 complex modulates the cellular signaling of neurotensin in the HT29 cell line☆☆

Institut de Pharmacologie Moléculaire et Cellulaire, Sophia Antipolis, Valbonne, France

Received 25 March 2002; accepted 27 June 2002.

Abstract 

Background & Aims: The neuropeptide neurotensin (NT) exerts its intracellular effect by interacting with 3 different receptors. Two of these receptors (NTR1 and NTR2) belong to the G protein–coupled receptor family, whereas the third one (NTR3) is a type I receptor with a single transmembrane domain. We recently showed that the 2 structurally different receptors NTR1 and NTR3 were coexpressed in several human cancer cells on which NT exerts proliferative effects. Methods: Here, by an immunoprecipitation approach, we provide biochemical evidence for an endogenous heterodimerization of the G protein–coupled receptor NTR1 with the NTR3 in the human adenocarcinoma cell line HT29. Results: We show that both receptors are expressed and colocalized within the cell surface of HT29 cells where they already interact to form a heterodimer. The NTR1-NTR3 complex is then internalized on NT stimulation. Conclusions: The complex formed between these 2 structurally unrelated NT receptors modulates both the NT-induced phosphorylation of mitogen-activated protein kinases and the phosphoinositide (PI) turnover mediated by the NTR1.

GASTROENTEROLOGY 2002;123:1135-1143

Abbreviations:  CHO , Chinese hamster ovary, CRLR , calcitonin receptor–like receptor, EC50, 50% of the maximal effective concentration, Erk , extracellular signal–regulated, GPCR , G protein–coupled receptor, HRP , horseradish peroxidase, MAP , mitogen-activated protein, NTR , neurotensin receptors, PI , phosphoinositide, RAMP , receptor activity–modifying protein, SDS , sodium dodecyl sulfate

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Address requests for reprints to: Jean Mazella, Ph.D., Institut de Pharmacologie Moléculaire et Cellulaire, Unité Mixte de Recherche 6097 du Centre National de la Recherche Scientifique, 660 route des lucioles, Sophia Antipolis, 06560 Valbonne, France. e-mail: mazella@ipmc.cnrs.fr; fax: (33) 4-93957708.

☆☆ S.M. and V.N. are fellowship recipients of the Association pour la Recherche contre le Cancer (ARC).

 The authors thank P. Kitabgi for complementary DNA encoding the human NTR1, M. S. Nielsen and C. M. Petersen (University of Aarhus, Denmark) for the gift of anti-sortilin/NTR3 and anti-propeptide antibodies and of sortilin-expressing CHO cells.

PII: S0016-5085(02)00219-6

doi:10.1053/gast.2002.36000

Gastroenterology
Volume 123, Issue 4 , Pages 1135-1143, October 2002